Initial treatment in patient with VIPoma is prompt replacement of fluid and correction of electrolyte imbalance and acid-base disturbance. Somatostatin analogues like short acting octreotide is useful for controlling diarrhea by blocking the release of VIP. Octreotide is later replaced by longer acting depot preparation of somatostatin analogues like sandostatin or lanreotide.
VIPoma medical therapy
VIPoma interventions
VIPoma secondary prevention
VIPoma surgery
Glomus tumor medical therapy
Glucagonoma medical therapy
Glioma medical therapy
Germinoma medical therapy